Vemlidy (Tenofovir Alafenamide) for Treatment of Chronic Hepatitis B Virus Infection
Developed by Gilead Sciences, Vemlidy (Tenofovir Alafenamide) is indicated for the treatment of Hepatitis B virus infection with compensated liver disease in adult patients.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Hepatitis | Hepatitis B | Liver | Liver Disease | Pharmaceuticals | Urology & Nephrology | Viread